EMA, EUnetHTA Sign Off on Three-Year Work Plan
By Michael Mezher -
Published 13 November 2017
The European Medicines Agency (EMA) and the European Network for Health Technology Assessment (EUnetHTA) on Monday detailed their priorities for the next three years in a joint work plan.
Categories: News, Europe, EMA, Biologics and biotechnology, Drugs, Reimbursement, Submission and registration
Tags: EUnetHTA, HTA, Health Technology Assessment, Parallel Advice